Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone binding	ATRX SMARCA2 SMARCA4 CHD8 TAF1 EZH1 CXXC1 CBX2	4.47e-06	265	71	8	GO:0042393
GeneOntologyMolecularFunction	modification-dependent protein binding	ATRX SMARCA4 CHD8 TAF1 CXXC1 VAV1 CBX2	8.54e-06	206	71	7	GO:0140030
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	ATRX SMARCA2 SMARCA4 CHD8	8.87e-06	37	71	4	GO:0140658
GeneOntologyMolecularFunction	chromatin binding	TRIM33 ATRX LEMD3 KAT8 TADA2B SMARCA2 SMARCA4 CHD8 TAF1 EZH1 BAP1 CBX2	1.04e-05	739	71	12	GO:0003682
GeneOntologyMolecularFunction	methylated histone binding	ATRX CHD8 TAF1 CXXC1 CBX2	1.37e-05	86	71	5	GO:0035064
GeneOntologyMolecularFunction	methylation-dependent protein binding	ATRX CHD8 TAF1 CXXC1 CBX2	1.53e-05	88	71	5	GO:0140034
GeneOntologyMolecularFunction	p53 binding	NOP53 SMARCA4 CHD8 TAF1	1.63e-04	77	71	4	GO:0002039
GeneOntologyMolecularFunction	helicase activity	ATRX SMARCA2 SMARCA4 CHD8 DHX8	2.49e-04	158	71	5	GO:0004386
GeneOntologyMolecularFunction	acetyltransferase activity	MEAF6 KAT8 TAF1 NAA16	5.16e-04	104	71	4	GO:0016407
GeneOntologyMolecularFunction	histone H4K8 acetyltransferase activity	MEAF6 KAT8	6.72e-04	11	71	2	GO:0043996
GeneOntologyMolecularFunction	histone H4K5 acetyltransferase activity	MEAF6 KAT8	6.72e-04	11	71	2	GO:0043995
GeneOntologyMolecularFunction	transcription coactivator activity	KAT8 TADA2B GPS2 SMARCA2 SMARCA4 MTDH	7.28e-04	303	71	6	GO:0003713
GeneOntologyMolecularFunction	histone acetyltransferase activity	MEAF6 KAT8 TAF1	7.94e-04	51	71	3	GO:0004402
GeneOntologyMolecularFunction	peptide-lysine-N-acetyltransferase activity	MEAF6 KAT8 TAF1	9.90e-04	55	71	3	GO:0061733
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	ATRX SMARCA2 SMARCA4 CHD8	1.09e-03	127	71	4	GO:0008094
GeneOntologyMolecularFunction	peptide N-acetyltransferase activity	MEAF6 KAT8 TAF1	1.27e-03	60	71	3	GO:0034212
GeneOntologyMolecularFunction	histone modifying activity	MEAF6 KAT8 TAF1 EZH1 BAP1	1.34e-03	229	71	5	GO:0140993
GeneOntologyMolecularFunction	calmodulin binding	ATP5IF1 MYO9B ASPM PLCB3 FAS	1.36e-03	230	71	5	GO:0005516
GeneOntologyMolecularFunction	N-acetyltransferase activity	MEAF6 KAT8 TAF1	2.71e-03	78	71	3	GO:0008080
GeneOntologyMolecularFunction	chromatin DNA binding	ATRX LEMD3 SMARCA4 BAP1	2.97e-03	167	71	4	GO:0031490
GeneOntologyMolecularFunction	histone H4 acetyltransferase activity	MEAF6 KAT8	3.01e-03	23	71	2	GO:0010485
GeneOntologyMolecularFunction	promoter-specific chromatin binding	TRIM33 KAT8 TAF1	3.23e-03	83	71	3	GO:1990841
GeneOntologyMolecularFunction	transcription coregulator activity	KAT8 TADA2B GPS2 SMARCA2 SMARCA4 EZH1 MTDH	3.78e-03	562	71	7	GO:0003712
GeneOntologyBiologicalProcess	protein-DNA complex organization	MEAF6 BDP1 ATRX KAT8 TADA2B MKI67 SMARCA2 SMARCA4 CHD8 RNF40 TAF1 EZH1 BAP1 CBX2	3.16e-06	999	67	14	GO:0071824
GeneOntologyBiologicalProcess	chromatin organization	MEAF6 ATRX KAT8 TADA2B MKI67 SMARCA2 SMARCA4 CHD8 RNF40 TAF1 EZH1 BAP1 CBX2	5.17e-06	896	67	13	GO:0006325
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	TRIM33 TFEC NOP53 KAT8 GPS2 PITX1 SMARCA2 SMARCA4 CHD8 ATP8B1 TAF1 EZH1 MTDH MXD4 BAP1 CBX2	7.61e-06	1399	67	16	GO:0045892
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	TRIM33 TFEC NOP53 KAT8 GPS2 PITX1 SMARCA2 SMARCA4 CHD8 ATP8B1 TAF1 EZH1 MTDH MXD4 BAP1 CBX2	8.63e-06	1413	67	16	GO:1902679
GeneOntologyBiologicalProcess	regulation of cell cycle	MEAF6 MAP9 CEP85 FAM107A ATRX LEMD3 NOP53 MKI67 ASPM SMARCA2 SMARCA4 RNF40 TAF1 BAP1	4.19e-05	1256	67	14	GO:0051726
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	TFEC ATRX EGR4 KAT8 GPS2 PITX1 SMARCA2 SMARCA4 CHD8 RNF40 TAF1 EZH1 BSX ZNF292	1.25e-04	1390	67	14	GO:0045944
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	TRIM33 TFEC NOP53 GPS2 SMARCA2 SMARCA4 CHD8 TAF1 EZH1 MTDH MXD4 CBX2	1.31e-04	1053	67	12	GO:0000122
GeneOntologyBiologicalProcess	chromatin remodeling	MEAF6 ATRX KAT8 TADA2B SMARCA2 SMARCA4 CHD8 TAF1 EZH1 BAP1	1.31e-04	741	67	10	GO:0006338
GeneOntologyBiologicalProcess	aortic smooth muscle cell differentiation	SMARCA2 SMARCA4	1.55e-04	6	67	2	GO:0035887
GeneOntologyCellularComponent	chromatin	MEAF6 TRIM33 TFEC ATRX EGR4 NOP53 KAT8 TADA2B PITX1 SMARCA2 SMARCA4 CHD8 RNF40 TAF1 EZH1 MXD4 BSX CBX2	1.88e-06	1480	72	18	GO:0000785
GeneOntologyCellularComponent	histone methyltransferase complex	KAT8 CHD8 TAF1 EZH1 CXXC1	6.02e-06	75	72	5	GO:0035097
GeneOntologyCellularComponent	heterochromatin	ATRX NOP53 SMARCA4 EZH1 CBX2	2.58e-05	101	72	5	GO:0000792
GeneOntologyCellularComponent	methyltransferase complex	KAT8 CHD8 TAF1 EZH1 CXXC1	3.56e-05	108	72	5	GO:0034708
GeneOntologyCellularComponent	MLL1 complex	KAT8 CHD8 TAF1	1.81e-04	32	72	3	GO:0071339
GeneOntologyCellularComponent	MLL1/2 complex	KAT8 CHD8 TAF1	1.98e-04	33	72	3	GO:0044665
GeneOntologyCellularComponent	protein acetyltransferase complex	MEAF6 KAT8 TADA2B NAA16	4.59e-04	104	72	4	GO:0031248
GeneOntologyCellularComponent	bBAF complex	SMARCA2 SMARCA4	5.17e-04	10	72	2	GO:0140092
GeneOntologyCellularComponent	acetyltransferase complex	MEAF6 KAT8 TADA2B NAA16	5.48e-04	109	72	4	GO:1902493
GeneOntologyCellularComponent	PcG protein complex	EZH1 BAP1 CBX2	7.67e-04	52	72	3	GO:0031519
GeneOntologyCellularComponent	npBAF complex	SMARCA2 SMARCA4	1.04e-03	14	72	2	GO:0071564
GeneOntologyCellularComponent	GBAF complex	SMARCA2 SMARCA4	1.04e-03	14	72	2	GO:0140288
GeneOntologyCellularComponent	nBAF complex	SMARCA2 SMARCA4	1.36e-03	16	72	2	GO:0071565
GeneOntologyCellularComponent	transferase complex	MEAF6 KAT8 TADA2B CHD8 RNF40 TAF1 EZH1 CXXC1 CBX2 NAA16	1.65e-03	963	72	10	GO:1990234
GeneOntologyCellularComponent	postsynaptic actin cytoskeleton	FAM107A MYO9B	1.93e-03	19	72	2	GO:0098871
GeneOntologyCellularComponent	nuclear protein-containing complex	KAT8 SMARCA2 SMARCA4 CHD8 TAF1 EZH1 CXXC1 MXD4 BAP1 DHX8 CBX2 KPNA3	2.46e-03	1377	72	12	GO:0140513
GeneOntologyCellularComponent	chromosome, centromeric region	MEAF6 ATRX KAT8 MKI67 SMARCA4	2.63e-03	276	72	5	GO:0000775
GeneOntologyCellularComponent	chromosomal region	MEAF6 ATRX KAT8 MKI67 SMARCA4 EZH1	3.28e-03	421	72	6	GO:0098687
GeneOntologyCellularComponent	postsynaptic cytoskeleton	FAM107A MYO9B	3.60e-03	26	72	2	GO:0099571
GeneOntologyCellularComponent	nuclear body	FAM107A ATRX MKI67 ATP8B1 FAS CXXC1 MTDH PALB2 DHX8	3.73e-03	903	72	9	GO:0016604
GeneOntologyCellularComponent	condensed chromosome	MEAF6 ATRX KAT8 MKI67 SMARCA4	4.15e-03	307	72	5	GO:0000793
GeneOntologyCellularComponent	histone acetyltransferase complex	MEAF6 KAT8 TADA2B	4.20e-03	94	72	3	GO:0000123
GeneOntologyCellularComponent	transcription regulator complex	BDP1 GPS2 PITX1 TAF1 MXD4 BSX NAA16	4.39e-03	596	72	7	GO:0005667
GeneOntologyCellularComponent	condensed chromosome, centromeric region	MEAF6 ATRX KAT8 SMARCA4	4.44e-03	193	72	4	GO:0000779
GeneOntologyCellularComponent	SWI/SNF complex	SMARCA2 SMARCA4	4.78e-03	30	72	2	GO:0016514
GeneOntologyCellularComponent	NuA4 histone acetyltransferase complex	MEAF6 KAT8	5.43e-03	32	72	2	GO:0035267
GeneOntologyCellularComponent	H4/H2A histone acetyltransferase complex	MEAF6 KAT8	5.43e-03	32	72	2	GO:0043189
HumanPheno	Abnormality of globe location	PIEZO2 ATRX LEMD3 KAT8 PITX1 DEF6 ASPM SMARCA2 CHD8 PLCB3 TAF1 DBR1 PALB2 BAP1 ZNF292 RPL18	2.98e-05	1122	27	16	HP:0100886
HumanPheno	Hyperactivity	PIEZO2 ATRX KAT8 ASPM SMARCA2 SMARCA4 CHD8 TAF1 BAP1 ZNF292 KPNA3	6.23e-05	558	27	11	HP:0000752
HumanPheno	Hypertelorism	PIEZO2 ATRX LEMD3 PITX1 DEF6 SMARCA2 CHD8 PLCB3 TAF1 DBR1 PALB2 ZNF292 RPL18	1.11e-04	830	27	13	HP:0000316
HumanPheno	Abnormality of globe location or size	PIEZO2 ATRX LEMD3 KAT8 PITX1 DEF6 ASPM SMARCA2 CHD8 PLCB3 TAF1 DBR1 PALB2 BAP1 ZNF292 RPL18	1.17e-04	1246	27	16	HP:0000489
HumanPheno	Abnormal 5th finger morphology	MIA3 PIEZO2 ATRX LEMD3 KAT8 PITX1 SMARCA2 SMARCA4 PALB2 ZNF292	1.59e-04	509	27	10	HP:0004207
HumanPheno	Attention deficit hyperactivity disorder	PIEZO2 KAT8 ASPM SMARCA2 CHD8 TAF1 BAP1 ZNF292 KPNA3	1.73e-04	413	27	9	HP:0007018
HumanPheno	Clinodactyly of the 5th finger	MIA3 PIEZO2 ATRX LEMD3 KAT8 PITX1 SMARCA2 PALB2 ZNF292	1.97e-04	420	27	9	HP:0004209
HumanPheno	Clinodactyly of hands	MIA3 PIEZO2 ATRX LEMD3 KAT8 PITX1 SMARCA2 PALB2 ZNF292	2.01e-04	421	27	9	HP:0001157
HumanPheno	Deviation of the 5th finger	MIA3 PIEZO2 ATRX LEMD3 KAT8 PITX1 SMARCA2 PALB2 ZNF292	2.01e-04	421	27	9	HP:0009179
HumanPheno	Abnormal nasal bridge morphology	MIA3 PIEZO2 ATRX LEMD3 KAT8 PITX1 SMARCA2 SMARCA4 CHD8 PLCB3 TAF1 DBR1 ZNF292 RPL18	2.45e-04	1029	27	14	HP:0000422
HumanPheno	Deviation of finger	MIA3 PIEZO2 ATRX LEMD3 KAT8 PITX1 SMARCA2 PALB2 BAP1 ZNF292	2.49e-04	537	27	10	HP:0004097
HumanPheno	Reduced impulse control	PIEZO2 ATRX LEMD3 KAT8 ASPM SMARCA2 SMARCA4 CHD8 TAF1 FAS PALB2 BAP1 ZNF292 KPNA3	2.53e-04	1032	27	14	HP:5200045
Domain	NPIP	NPIPB8 NPIPB15 NPIPB9 NPIPB6	2.21e-07	14	74	4	IPR009443
Domain	BRK	SMARCA2 SMARCA4 CHD8	1.18e-06	6	74	3	SM00592
Domain	BRK_domain	SMARCA2 SMARCA4 CHD8	1.18e-06	6	74	3	IPR006576
Domain	BRK	SMARCA2 SMARCA4 CHD8	1.18e-06	6	74	3	PF07533
Domain	SNF2_N	ATRX SMARCA2 SMARCA4 CHD8	7.51e-06	32	74	4	IPR000330
Domain	SNF2_N	ATRX SMARCA2 SMARCA4 CHD8	7.51e-06	32	74	4	PF00176
Domain	BROMODOMAIN_1	TRIM33 SMARCA2 SMARCA4 TAF1	1.36e-05	37	74	4	PS00633
Domain	Bromodomain	TRIM33 SMARCA2 SMARCA4 TAF1	1.51e-05	38	74	4	PF00439
Domain	SnAC	SMARCA2 SMARCA4	1.55e-05	2	74	2	SM01314
Domain	Gln-Leu-Gln_QLQ	SMARCA2 SMARCA4	1.55e-05	2	74	2	IPR014978
Domain	SnAC	SMARCA2 SMARCA4	1.55e-05	2	74	2	IPR029295
Domain	SnAC	SMARCA2 SMARCA4	1.55e-05	2	74	2	PF14619
Domain	QLQ	SMARCA2 SMARCA4	1.55e-05	2	74	2	SM00951
Domain	QLQ	SMARCA2 SMARCA4	1.55e-05	2	74	2	PS51666
Domain	QLQ	SMARCA2 SMARCA4	1.55e-05	2	74	2	PF08880
Domain	BROMODOMAIN_2	TRIM33 SMARCA2 SMARCA4 TAF1	2.06e-05	41	74	4	PS50014
Domain	BROMO	TRIM33 SMARCA2 SMARCA4 TAF1	2.27e-05	42	74	4	SM00297
Domain	Bromodomain	TRIM33 SMARCA2 SMARCA4 TAF1	2.27e-05	42	74	4	IPR001487
Domain	-	TRIM33 SMARCA2 SMARCA4 TAF1	2.27e-05	42	74	4	1.20.920.10
Domain	Helicase_C	ATRX SMARCA2 SMARCA4 CHD8 DHX8	6.61e-05	107	74	5	PF00271
Domain	HELICc	ATRX SMARCA2 SMARCA4 CHD8 DHX8	6.61e-05	107	74	5	SM00490
Domain	Helicase_C	ATRX SMARCA2 SMARCA4 CHD8 DHX8	6.91e-05	108	74	5	IPR001650
Domain	HELICASE_CTER	ATRX SMARCA2 SMARCA4 CHD8 DHX8	7.22e-05	109	74	5	PS51194
Domain	HELICASE_ATP_BIND_1	ATRX SMARCA2 SMARCA4 CHD8 DHX8	7.22e-05	109	74	5	PS51192
Domain	DEXDc	ATRX SMARCA2 SMARCA4 CHD8 DHX8	7.22e-05	109	74	5	SM00487
Domain	Helicase_ATP-bd	ATRX SMARCA2 SMARCA4 CHD8 DHX8	7.54e-05	110	74	5	IPR014001
Domain	HSA	SMARCA2 SMARCA4	9.24e-05	4	74	2	SM00573
Domain	HSA	SMARCA2 SMARCA4	9.24e-05	4	74	2	PS51204
Domain	HSA_dom	SMARCA2 SMARCA4	9.24e-05	4	74	2	IPR014012
Domain	HSA	SMARCA2 SMARCA4	9.24e-05	4	74	2	PF07529
Domain	Bromodomain_CS	SMARCA2 SMARCA4 TAF1	1.45e-04	26	74	3	IPR018359
Domain	CHROMO_1	KAT8 CHD8 CBX2	1.82e-04	28	74	3	PS00598
Domain	CHROMO_2	KAT8 CHD8 CBX2	1.82e-04	28	74	3	PS50013
Domain	Chromodomain-like	KAT8 CHD8 CBX2	2.73e-04	32	74	3	IPR016197
Domain	Chromo/shadow_dom	KAT8 CHD8 CBX2	2.99e-04	33	74	3	IPR000953
Domain	CHROMO	KAT8 CHD8 CBX2	2.99e-04	33	74	3	SM00298
Domain	CAMSAP_CH	ASPM VAV1	3.21e-04	7	74	2	PF11971
Domain	CAMSAP_CH	ASPM VAV1	3.21e-04	7	74	2	IPR022613
Domain	SANT	BDP1 TADA2B EZH1	1.02e-03	50	74	3	SM00717
Domain	SANT/Myb	BDP1 TADA2B EZH1	1.15e-03	52	74	3	IPR001005
Domain	IQ	MYO9B SCN10A ASPM	2.81e-03	71	74	3	PF00612
Domain	Znf_RING_CS	TRIM33 TRIM61 RNF40 PDZRN3	4.00e-03	163	74	4	IPR017907
Domain	Chromo_domain	CHD8 CBX2	4.04e-03	24	74	2	IPR023780
Domain	Chromo	CHD8 CBX2	4.73e-03	26	74	2	PF00385
Pathway	WP_KLEEFSTRA_SYNDROME	SMARCA2 SMARCA4 BAP1	1.05e-04	29	45	3	M48076
Pathway	REACTOME_RAC2_GTPASE_CYCLE	SWAP70 LEMD3 DEF6 VAV1	1.74e-04	88	45	4	M41810
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	MEAF6 KAT8 TADA2B GPS2 SMARCA2 SMARCA4	2.11e-04	272	45	6	M29619
Pathway	REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN	SMARCA2 SMARCA4 CBX2	2.19e-04	37	45	3	M27797
Pathway	REACTOME_RAC1_GTPASE_CYCLE	SWAP70 LEMD3 MYO9B DEF6 VAV1	2.87e-04	184	45	5	M41809
Pathway	PID_RHOA_REG_PATHWAY	MYO9B DEF6 VAV1	4.19e-04	46	45	3	M68
Pathway	WP_RETT_SYNDROME	GPS2 SMARCA2 SMARCA4	4.76e-04	48	45	3	M39759
Pubmed	Human transcription factor protein interaction networks.	MEAF6 TRIM33 CEP85 ATRX CCDC174 NOP53 PRRC2C KAT8 TADA2B GPS2 PITX1 MKI67 SMARCA2 SMARCA4 CHD8 GPATCH4 TAF1 MAP7 CCDC86 CXXC1 BAP1 CBX2	4.23e-13	1429	78	22	35140242
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	MEAF6 TRIM33 ATP5IF1 ATRX LEMD3 CCDC174 NOP53 PRRC2C MKI67 SMARCA4 CHD8 GPATCH4 TAF1 C2orf49 CCDC86 MTDH CBX2 KPNA3	2.99e-12	954	78	18	36373674
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	MEAF6 ATRX LEMD3 KAT8 TADA2B GPS2 PITX1 MKI67 SMARCA4 GPATCH4 RNF40 MAP7 CCDC86 CXXC1 MTDH MXD4 PALB2 BAP1 DHX8 RPL18	5.67e-12	1294	78	20	30804502
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	MEAF6 ATRX KAT8 TADA2B PITX1 MKI67 SMARCA4 CHD8 GPATCH4 TAF1 CCDC86 BAP1 DHX8 ZNF292 CBX2	5.81e-12	608	78	15	36089195
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	BDP1 TRIM33 CEP85 ATRX MYO9B CCDC174 PRRC2C RABEP1 ASPM RNF40 MAP7 GOLGB1	7.68e-09	588	78	12	38580884
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	TRIM33 TADA2B GPS2 SMARCA2 SMARCA4 CHD8 RNF40 TAF1 BAP1	9.61e-09	268	78	9	33640491
Pubmed	Interaction network of human early embryonic transcription factors.	MEAF6 TRIM33 GPS2 PITX1 MKI67 SMARCA2 SMARCA4 CHD8 TAF1	9.69e-08	351	78	9	38297188
Pubmed	The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing.	NOP53 PRRC2C MKI67 SMARCA4 GPATCH4 CCDC86 MTDH DHX8 RPL18 KPNA3	1.32e-07	483	78	10	36912080
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MEAF6 TRIM33 TADA2B ASPM SMARCA2 SMARCA4 CHD8 GPATCH4 TAF1 MAP7 EZH1 PDZRN3 VAV1 KPNA3	1.71e-07	1116	78	14	31753913
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	MEAF6 CRACD TFEC CEP85 ATRX TADA2B GPS2 ASPM CHD8 GPATCH4 C2orf68 BAP1 ZNF292 RPL18 KPNA3	2.23e-07	1327	78	15	32694731
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	ATRX MYO9B NOP53 MKI67 SMARCA2 SMARCA4 CHD8 TAF1 CCDC86 KPNA3	3.25e-07	533	78	10	30554943
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	MEAF6 ANKRD36B CEP85 PRRC2C TADA2B MKI67 SMARCA4 GPATCH4 DBR1 C2orf49 CCDC86 C2orf68 MTDH CBX2 KPNA3	3.38e-07	1371	78	15	36244648
Pubmed	Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease.	PITX1 SMARCA2 SMARCA4	3.77e-07	7	78	3	17043312
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	MEAF6 TRIM33 TADA2B SMARCA4 CHD8 BAP1	5.98e-07	134	78	6	25452129
Pubmed	New insights into BS69 functions.	SMARCA2 SMARCA4 EZH1	6.03e-07	8	78	3	16565076
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	MIA3 ATRX LEMD3 MKI67 SMARCA2 SMARCA4 CHD8 RNF40 RPL18	6.45e-07	440	78	9	34244565
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TRIM33 CCDC174 PRRC2C KAT8 GPS2 PITX1 MKI67 SMARCA2 SMARCA4 CHD8 C2orf49 PALB2 ZNF292	9.99e-07	1103	78	13	34189442
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	TRIM33 CRACD ATRX LEMD3 NOP53 KAT8 TADA2B SMARCA2 CHD8 GPATCH4 MAP7 CCDC86 GOLGB1 DHX8 KPNA3	1.02e-06	1497	78	15	31527615
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	MYO9B NOP53 PRRC2C MKI67 ASPM SMARCA4 GPATCH4 CCDC86 MTDH DHX8 RPL18	1.03e-06	759	78	11	35915203
Pubmed	Temporally controlled targeted somatic mutagenesis in embryonic surface ectoderm and fetal epidermal keratinocytes unveils two distinct developmental functions of BRG1 in limb morphogenesis and skin barrier formation.	MKI67 SMARCA2 SMARCA4	1.29e-06	10	78	3	16192310
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	BDP1 MKI67 SMARCA2 SMARCA4 PDZRN3 PALB2 DHX8	1.56e-06	250	78	7	33536335
Pubmed	Dual Requirement of CHD8 for Chromatin Landscape Establishment and Histone Methyltransferase Recruitment to Promote CNS Myelination and Repair.	MKI67 SMARCA4 CHD8	3.05e-06	13	78	3	29920279
Pubmed	Bmx is a downstream Rap1 effector in VEGF-induced endothelial cell activation.	SMARCA2 SMARCA4 FAS	3.05e-06	13	78	3	15207703
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	ATRX MKI67 SMARCA4 CHD8 TAF1 MTDH DHX8	3.54e-06	283	78	7	30585729
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	NOP53 MKI67 SMARCA2 CHD8 GPATCH4 CCDC86 CXXC1 RPL18	3.98e-06	410	78	8	26949251
Pubmed	Nucleolar proteome dynamics.	ATP5IF1 ATRX NOP53 SMARCA4 GPATCH4 DHX8 RPL18 KPNA3	4.66e-06	419	78	8	15635413
Pubmed	The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis.	SMARCA2 SMARCA4	4.97e-06	2	78	2	8670841
Pubmed	Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features.	SMARCA2 SMARCA4	4.97e-06	2	78	2	23163725
Pubmed	Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development.	SMARCA2 SMARCA4	4.97e-06	2	78	2	23076393
Pubmed	The SWI/SNF chromatin remodeling protein Brg1 is required for vertebrate neurogenesis and mediates transactivation of Ngn and NeuroD.	SMARCA2 SMARCA4	4.97e-06	2	78	2	15576411
Pubmed	Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.	SMARCA2 SMARCA4	4.97e-06	2	78	2	15240517
Pubmed	Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.	SMARCA2 SMARCA4	4.97e-06	2	78	2	26564006
Pubmed	SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction.	SMARCA2 SMARCA4	4.97e-06	2	78	2	33027072
Pubmed	A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.	SMARCA2 SMARCA4	4.97e-06	2	78	2	23872584
Pubmed	Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.	SMARCA2 SMARCA4	4.97e-06	2	78	2	23088494
Pubmed	SWI/SNF chromatin remodeling enzyme ATPases promote cell proliferation in normal mammary epithelial cells.	SMARCA2 SMARCA4	4.97e-06	2	78	2	20333683
Pubmed	SWI/SNF Complex-deficient Undifferentiated Carcinoma of the Gastrointestinal Tract: Clinicopathologic Study of 30 Cases With an Emphasis on Variable Morphology, Immune Features, and the Prognostic Significance of Different SMARCA4 and SMARCA2 Subunit Deficiencies.	SMARCA2 SMARCA4	4.97e-06	2	78	2	34812766
Pubmed	Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy.	SMARCA2 SMARCA4	4.97e-06	2	78	2	30478150
Pubmed	The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation.	SMARCA2 SMARCA4	4.97e-06	2	78	2	25808524
Pubmed	Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation.	SMARCA2 SMARCA4	4.97e-06	2	78	2	19144648
Pubmed	CCDC86 is a novel Ki-67-interacting protein important for cell division.	MKI67 CCDC86	4.97e-06	2	78	2	36695333
Pubmed	High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.	SMARCA2 SMARCA4	4.97e-06	2	78	2	29391527
Pubmed	Expression of SMARCA2 and SMARCA4 in gastric adenocarcinoma and construction of a nomogram prognostic model.	SMARCA2 SMARCA4	4.97e-06	2	78	2	37634210
Pubmed	Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor.	SMARCA2 SMARCA4	4.97e-06	2	78	2	8208605
Pubmed	A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes.	SMARCA2 SMARCA4	4.97e-06	2	78	2	11163203
Pubmed	Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes.	SMARCA2 SMARCA4	4.97e-06	2	78	2	12620226
Pubmed	BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivo.	SMARCA2 SMARCA4	4.97e-06	2	78	2	27039070
Pubmed	Partial Inactivation of the Chromatin Remodelers SMARCA2 and SMARCA4 in Virus-Infected Cells by Caspase-Mediated Cleavage.	SMARCA2 SMARCA4	4.97e-06	2	78	2	29848589
Pubmed	Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein.	SMARCA2 SMARCA4	4.97e-06	2	78	2	9603422
Pubmed	SWI/SNF gene variants and glioma risk and outcome.	SMARCA2 SMARCA4	4.97e-06	2	78	2	23276717
Pubmed	Differential Expression of SWI/SNF Chromatin Remodeler Subunits Brahma and Brahma-Related Gene During Drug-Induced Liver Injury and Regeneration in Mouse Model.	SMARCA2 SMARCA4	4.97e-06	2	78	2	27097303
Pubmed	SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens.	SMARCA2 SMARCA4	4.97e-06	2	78	2	28038711
Pubmed	Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury.	SMARCA2 SMARCA4	4.97e-06	2	78	2	23963727
Pubmed	SW13 cells can transition between two distinct subtypes by switching expression of BRG1 and Brm genes at the post-transcriptional level.	SMARCA2 SMARCA4	4.97e-06	2	78	2	12493776
Pubmed	Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4.	SMARCA2 SMARCA4	4.97e-06	2	78	2	31375262
Pubmed	Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.	SMARCA2 SMARCA4	4.97e-06	2	78	2	17075831
Pubmed	Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma.	SMARCA2 SMARCA4	4.97e-06	2	78	2	32855269
Pubmed	Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity.	SMARCA2 SMARCA4	4.97e-06	2	78	2	22721696
Pubmed	Chromatin remodeling complexes interact dynamically with a glucocorticoid receptor-regulated promoter.	SMARCA2 SMARCA4	4.97e-06	2	78	2	18508913
Pubmed	Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling.	SMARCA2 SMARCA4	4.97e-06	2	78	2	11719516
Pubmed	Expression patterns of astrocyte elevated gene-1 (AEG-1) during development of the mouse embryo.	MKI67 MTDH	4.97e-06	2	78	2	20736086
Pubmed	Control of GM-CSF-Dependent Dendritic Cell Differentiation and Maturation by DEF6 and SWAP-70.	SWAP70 DEF6	4.97e-06	2	78	2	32709659
Pubmed	SWEF Proteins Distinctly Control Maintenance and Differentiation of Hematopoietic Stem Cells.	SWAP70 DEF6	4.97e-06	2	78	2	27561029
Pubmed	DNA binding drives the association of BRG1/hBRM bromodomains with nucleosomes.	SMARCA2 SMARCA4	4.97e-06	2	78	2	28706277
Pubmed	A Cross Talk Between BRG1 and Males Absent on the First Contributes to Reactive Oxygen Species Production in a Mouse Model of Nonalcoholic Steatohepatitis.	KAT8 SMARCA4	4.97e-06	2	78	2	29963902
Pubmed	[Expression of BRG1 and BRM proteins in prostatic cancer].	SMARCA2 SMARCA4	4.97e-06	2	78	2	21092585
Pubmed	SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.	SMARCA2 SMARCA4	4.97e-06	2	78	2	26551623
Pubmed	SWI/SNF deficiency results in aberrant chromatin organization, mitotic failure, and diminished proliferative capacity.	SMARCA2 SMARCA4	4.97e-06	2	78	2	19458193
Pubmed	The Bromodomains of the mammalian SWI/SNF (mSWI/SNF) ATPases Brahma (BRM) and Brahma Related Gene 1 (BRG1) promote chromatin interaction and are critical for skeletal muscle differentiation.	SMARCA2 SMARCA4	4.97e-06	2	78	2	34289068
Pubmed	SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria.	SMARCA2 SMARCA4	4.97e-06	2	78	2	34518526
Pubmed	SMARCA family of genes.	SMARCA2 SMARCA4	4.97e-06	2	78	2	32312722
Pubmed	Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.	SMARCA2 SMARCA4	4.97e-06	2	78	2	26356327
Pubmed	Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.	SMARCA2 SMARCA4	4.97e-06	2	78	2	12566296
Pubmed	SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines.	SMARCA2 SMARCA4	4.97e-06	2	78	2	31406271
Pubmed	Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits.	SMARCA2 SMARCA4	4.97e-06	2	78	2	29273066
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	CEP85 SWAP70 PRRC2C TADA2B GKAP1 MKI67 GPATCH4 MTDH DHX8 ZNF292	5.05e-06	724	78	10	36232890
Pubmed	Identification of a polymorphic, neuron-specific chromatin remodeling complex.	MKI67 SMARCA2 SMARCA4	7.21e-06	17	78	3	12368262
Pubmed	TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation.	TRIM33 SMARCA2 SMARCA4	8.64e-06	18	78	3	28068325
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	TRIM33 ATRX NOP53 PRRC2C SMARCA4 CHD8 EZH1 KPNA3	1.06e-05	469	78	8	27634302
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	TRIM33 CCDC174 NOP53 TADA2B SMARCA4 CHD8 RNF40	1.15e-05	339	78	7	30415952
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	ATP5IF1 ATRX PRRC2C CHD8 RNF40 PLCB3 MTDH KPNA3	1.16e-05	475	78	8	31040226
Pubmed	A protein interaction landscape of breast cancer.	MKI67 SMARCA2 SMARCA4 GPATCH4 EZH1 MTDH PALB2 RPL18 KPNA3	1.25e-05	634	78	9	34591612
Pubmed	DNA damage sensitivity of SWI/SNF-deficient cells depends on TFIIH subunit p62/GTF2H1.	SMARCA2 SMARCA4	1.49e-05	3	78	2	30287812
Pubmed	Chromatin context and ncRNA highlight targets of MeCP2 in brain.	ATRX SMARCA4	1.49e-05	3	78	2	24270455
Pubmed	Def-6, a guanine nucleotide exchange factor for Rac1, interacts with the skeletal muscle integrin chain alpha7A and influences myoblast differentiation.	SWAP70 DEF6	1.49e-05	3	78	2	17403664
Pubmed	Interleukin-13 Receptor α1-Mediated Signaling Regulates Age-Associated/Autoimmune B Cell Expansion and Lupus Pathogenesis.	SWAP70 DEF6	1.49e-05	3	78	2	35438841
Pubmed	Piezo2 expressing nociceptors mediate mechanical sensitization in experimental osteoarthritis.	PIEZO2 SCN10A	1.49e-05	3	78	2	37120427
Pubmed	BRCA1 interacts with dominant negative SWI/SNF enzymes without affecting homologous recombination or radiation-induced gene activation of p21 or Mdm2.	SMARCA2 SMARCA4	1.49e-05	3	78	2	15034933
Pubmed	A putative nuclear receptor coactivator (TMF/ARA160) associates with hbrm/hSNF2 alpha and BRG-1/hSNF2 beta and localizes in the Golgi apparatus.	SMARCA2 SMARCA4	1.49e-05	3	78	2	12044884
Pubmed	SWI/SNF complexes containing Brahma or Brahma-related gene 1 play distinct roles in smooth muscle development.	SMARCA2 SMARCA4	1.49e-05	3	78	2	21518954
Pubmed	Characterization of mammary tumors from Brg1 heterozygous mice.	SMARCA2 SMARCA4	1.49e-05	3	78	2	17637742
Pubmed	IRF4-Dependent and IRF4-Independent Pathways Contribute to DC Dysfunction in Lupus.	SWAP70 DEF6	1.49e-05	3	78	2	26544714
Pubmed	Patterns and rates of exonic de novo mutations in autism spectrum disorders.	CHD8 ZNF292	1.49e-05	3	78	2	22495311
Pubmed	Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models.	SMARCA2 SMARCA4	1.49e-05	3	78	2	28292935
Pubmed	Clinicopathological and prognostic significance of SWI/SNF complex subunits in undifferentiated gastric carcinoma.	SMARCA2 SMARCA4	1.49e-05	3	78	2	36464671
Pubmed	The activity of p53 is differentially regulated by Brm- and Brg1-containing SWI/SNF chromatin remodeling complexes.	SMARCA2 SMARCA4	1.49e-05	3	78	2	17938176
Pubmed	Functional redundancy of SWI/SNF catalytic subunits in maintaining vascular endothelial cells in the adult heart.	SMARCA2 SMARCA4	1.49e-05	3	78	2	22740088
Pubmed	TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival.	SMARCA2 SMARCA4	1.49e-05	3	78	2	15075294
Pubmed	Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.	SMARCA2 SMARCA4	1.49e-05	3	78	2	19784067
Pubmed	BRG1 co-localizes with DNA replication factors and is required for efficient replication fork progression.	SMARCA2 SMARCA4	1.49e-05	3	78	2	20571081
Interaction	H2BC8 interactions	MEAF6 ATRX LEMD3 KAT8 MKI67 SMARCA4 CHD8 GPATCH4 CCDC86 CXXC1 PALB2 DHX8 ZNF292 CBX2 KPNA3	3.29e-09	576	76	15	int:H2BC8
Interaction	H3C3 interactions	MEAF6 ATRX KAT8 PITX1 MKI67 SMARCA4 CHD8 GPATCH4 TAF1 CCDC86 BAP1 DHX8 ZNF292 CBX2	4.13e-09	495	76	14	int:H3C3
Interaction	SMC5 interactions	MEAF6 TRIM33 ATP5IF1 ATRX LEMD3 CCDC174 NOP53 PRRC2C MKI67 SMARCA4 CHD8 GPATCH4 TAF1 C2orf49 CCDC86 MTDH CBX2 KPNA3	2.33e-08	1000	76	18	int:SMC5
Interaction	TERF2IP interactions	TRIM33 TADA2B MKI67 SMARCA4 CHD8 GPATCH4 RNF40 TAF1 FAS BAP1 DHX8 ZNF292 CBX2	1.34e-07	552	76	13	int:TERF2IP
Interaction	H3C1 interactions	TRIM33 PIEZO2 ATRX LEMD3 PRRC2C KAT8 TADA2B MKI67 SMARCA2 SMARCA4 CHD8 GPATCH4 TAF1 PALB2 ZNF292 CBX2	1.94e-07	901	76	16	int:H3C1
Interaction	ASF1A interactions	BDP1 TRIM33 ATRX KAT8 SMARCA4 CHD8 TAF1 FAS CBX2	4.02e-07	249	76	9	int:ASF1A
Interaction	KPNA1 interactions	MEAF6 TRIM33 TADA2B MKI67 SMARCA2 SMARCA4 CHD8 FAS BAP1 KPNA3	7.78e-07	351	76	10	int:KPNA1
Interaction	HNF4A interactions	TRIM33 ATRX KAT8 TADA2B GPS2 SMARCA2 SMARCA4 CXXC1 BAP1	9.23e-07	275	76	9	int:HNF4A
Interaction	NOP56 interactions	MIA3 ATRX NOP53 MKI67 SMARCA2 SMARCA4 GPATCH4 CCDC86 MTDH BAP1 RPL18 KPNA3	1.39e-06	570	76	12	int:NOP56
Interaction	NPM1 interactions	BDP1 SWAP70 MYO9B NOP53 PRRC2C MKI67 ASPM SMARCA4 CHD8 GPATCH4 CCDC86 MTDH BSX BAP1 CBX2 RPL18 KPNA3	1.81e-06	1201	76	17	int:NPM1
Interaction	ZCCHC10 interactions	ANKRD36B MYO9B GKAP1 ASPM SMARCA2 TAF1 DHX8 KPNA3	2.98e-06	236	76	8	int:ZCCHC10
Interaction	H3-3A interactions	MEAF6 ATRX KAT8 TADA2B PITX1 MKI67 SMARCA4 CHD8 TAF1 DHX8 ZNF292 CBX2 KPNA3	4.09e-06	749	76	13	int:H3-3A
Interaction	KPNA6 interactions	MEAF6 TRIM33 TADA2B CHD8 FAS BAP1 KPNA3	4.20e-06	174	76	7	int:KPNA6
Interaction	H2BC21 interactions	MEAF6 ATRX KAT8 MKI67 SMARCA4 CHD8 RNF40 CCDC86 PALB2 ZNF292 CBX2 NAA16	1.07e-05	696	76	12	int:H2BC21
Interaction	CSNK2A1 interactions	MEAF6 ANKRD36B BDP1 MAP9 ATRX NOP53 PRRC2C SMARCA4 ANKRD36 TAF1 ANKRD36C MTDH BAP1 CBX2	1.17e-05	956	76	14	int:CSNK2A1
Interaction	SLFN11 interactions	BDP1 TRIM33 MKI67 SMARCA2 SMARCA4 PDZRN3 PALB2 BAP1 DHX8	1.18e-05	376	76	9	int:SLFN11
Interaction	RSL1D1 interactions	NOP53 MKI67 SMARCA2 GPATCH4 CCDC86 MTDH BAP1 DHX8 RPL18 KPNA3	1.23e-05	479	76	10	int:RSL1D1
Interaction	H2AX interactions	ATRX KAT8 MKI67 SMARCA2 SMARCA4 CHD8 CCDC86 CXXC1 ZMAT1 PALB2 CBX2	1.32e-05	593	76	11	int:H2AX
Interaction	CSNK2A2 interactions	ANKRD36B ATP5IF1 ATRX NOP53 PRRC2C RABEP1 MKI67 SMARCA4 ANKRD36 ANKRD36C BAP1 CBX2	1.46e-05	718	76	12	int:CSNK2A2
Interaction	CBX3 interactions	TRIM33 ATRX LEMD3 MKI67 SMARCA4 CHD8 GPATCH4 EZH1 BAP1 DHX8 ZNF292	2.91e-05	646	76	11	int:CBX3
Interaction	KLF8 interactions	MEAF6 TRIM33 NOP53 PRRC2C TADA2B GPATCH4 MAP7 BAP1	3.33e-05	329	76	8	int:KLF8
Interaction	NUP50 interactions	TRIM33 LEMD3 GPATCH4 TAF1 CXXC1 DHX8 ZNF292 KPNA3	4.29e-05	341	76	8	int:NUP50
Interaction	PHF20 interactions	KAT8 CHD8 TAF1 CXXC1	4.75e-05	53	76	4	int:PHF20
Interaction	YY1 interactions	KAT8 MKI67 SMARCA4 CHD8 TAF1 EZH1 FAS CXXC1 BAP1	5.17e-05	454	76	9	int:YY1
Interaction	ASH2L interactions	BDP1 MKI67 CHD8 TAF1 CXXC1 BAP1 ZNF292	6.34e-05	265	76	7	int:ASH2L
Interaction	ELF4 interactions	TRIM33 KAT8 SMARCA2 CXXC1 BAP1	7.42e-05	115	76	5	int:ELF4
Interaction	USP36 interactions	NOP53 PRRC2C MKI67 SMARCA4 GPATCH4 CCDC86 MTDH DHX8 RPL18 KPNA3	8.16e-05	599	76	10	int:USP36
Interaction	CENPA interactions	ATRX LEMD3 NOP53 SMARCA2 GPATCH4 TAF1 ZNF292 CBX2	8.66e-05	377	76	8	int:CENPA
Interaction	LIN7C interactions	ATP5IF1 PPFIA4 PLCB3 VAV1 BAP1	8.72e-05	119	76	5	int:LIN7C
Interaction	POLR1G interactions	NOP53 SMARCA4 CHD8 GPATCH4 TAF1 BAP1 ZNF292 CBX2 KPNA3	9.13e-05	489	76	9	int:POLR1G
Interaction	MYOD1 interactions	TRIM33 TADA2B SMARCA2 SMARCA4 BAP1 KPNA3	9.20e-05	194	76	6	int:MYOD1
Interaction	RCOR1 interactions	RABEP1 GPS2 MKI67 SMARCA4 CHD8 RNF40 TAF1 PALB2 BAP1	9.86e-05	494	76	9	int:RCOR1
Interaction	CBX1 interactions	ATRX MKI67 SMARCA2 SMARCA4 BAP1 ZNF292 KPNA3	1.07e-04	288	76	7	int:CBX1
Interaction	MEN1 interactions	ATRX NOP53 MKI67 SMARCA4 CHD8 GPATCH4 TAF1 CCDC86 CXXC1 MTDH DHX8 RPL18 KPNA3	1.13e-04	1029	76	13	int:MEN1
Interaction	ELF1 interactions	KAT8 SMARCA2 TAF1 CXXC1 BAP1	1.14e-04	126	76	5	int:ELF1
Interaction	NUP43 interactions	NOP53 PRRC2C KAT8 MKI67 SMARCA4 CHD8 GPATCH4 DHX8 ZNF292 RPL18	1.16e-04	625	76	10	int:NUP43
Interaction	CHD3 interactions	ATP5IF1 PRRC2C GPS2 MKI67 SMARCA2 SMARCA4 GPATCH4 TAF1 MTDH RPL18 KPNA3	1.21e-04	757	76	11	int:CHD3
Interaction	EWSR1 interactions	TRIM33 MIA3 CEP85 PITX1 MKI67 ANO1 SMARCA4 RNF40 TAF1 GOLGB1 BAP1 ZNF292	1.38e-04	906	76	12	int:EWSR1
Interaction	MYB interactions	SMARCA2 GPATCH4 CXXC1 BAP1 ZNF292	1.47e-04	133	76	5	int:MYB
Interaction	IPO7 interactions	TRIM33 NPIPB6 ASPM MAP7 FAS BAP1 RPL18	1.49e-04	304	76	7	int:IPO7
Interaction	RBM27 interactions	TRIM33 ATRX EZH1 BAP1 DHX8	1.69e-04	137	76	5	int:RBM27
Interaction	KDM5C interactions	MEAF6 TRIM33 SMARCA4 PALB2 BAP1	1.81e-04	139	76	5	int:KDM5C
Interaction	FTSJ3 interactions	NOP53 MKI67 GPATCH4 TAF1 MTDH BAP1 DHX8 RPL18	1.88e-04	422	76	8	int:FTSJ3
Interaction	KLF16 interactions	CCDC174 NOP53 PRRC2C PITX1 GPATCH4 TAF1 MAP7 BAP1	1.97e-04	425	76	8	int:KLF16
Interaction	CEBPA interactions	TRIM33 CCDC174 PRRC2C KAT8 GPS2 PITX1 MKI67 SMARCA2 SMARCA4 CHD8 C2orf49 PALB2 ZNF292 NAA16	2.04e-04	1245	76	14	int:CEBPA
Interaction	CTAGE7P interactions	MIA3 GOLGB1	2.08e-04	6	76	2	int:CTAGE7P
Interaction	MEIOB interactions	FAM107A BAP1	2.08e-04	6	76	2	int:MEIOB
Interaction	FXR2 interactions	MEAF6 MIA3 PRRC2C GKAP1 MKI67 MAP7 MTDH BAP1	2.14e-04	430	76	8	int:FXR2
Interaction	RPL26L1 interactions	NOP53 MKI67 GPATCH4 MAP7 BAP1 DHX8 RPL18 KPNA3	2.17e-04	431	76	8	int:RPL26L1
Interaction	FOXP3 interactions	NOP53 KAT8 SMARCA4 CHD8 GPATCH4 TAF1 VAV1 KPNA3	2.20e-04	432	76	8	int:FOXP3
Interaction	AHCYL2 interactions	ANKRD36B FAM13C PITX1 BAP1 DHX8	2.21e-04	145	76	5	int:AHCYL2
Interaction	HDAC1 interactions	ATRX RABEP1 GPS2 MKI67 SMARCA2 SMARCA4 CHD8 RNF40 TAF1 PALB2 GOLGB1 BAP1 KPNA3	2.36e-04	1108	76	13	int:HDAC1
Interaction	SOX7 interactions	TRIM33 SMARCA2 SMARCA4 ZNF292	2.61e-04	82	76	4	int:SOX7
Interaction	CIT interactions	MYO9B NOP53 PRRC2C MKI67 SMARCA2 SMARCA4 CHD8 GPATCH4 RNF40 MAP7 CCDC86 MTDH DHX8 RPL18 KPNA3	2.91e-04	1450	76	15	int:CIT
Interaction	SLX4 interactions	TRIM33 ATRX NOP53 MKI67 SMARCA4 CHD8 GPATCH4 RPL18 KPNA3	2.95e-04	572	76	9	int:SLX4
Interaction	HECTD1 interactions	MYO9B NOP53 PRRC2C MKI67 ASPM SMARCA4 GPATCH4 TAF1 CCDC86 MTDH DHX8 RPL18	2.97e-04	984	76	12	int:HECTD1
Interaction	OTUD6B interactions	SWAP70 FAS MTDH RPL18	3.00e-04	85	76	4	int:OTUD6B
Interaction	RRBP1 interactions	TRIM33 ATRX PRRC2C MKI67 SMARCA4 CCDC191 MTDH	3.00e-04	341	76	7	int:RRBP1
Interaction	ELOA interactions	RABEP1 KAT8 RNF40 PLCB3 EZH1 DHX8	3.05e-04	242	76	6	int:ELOA
Interaction	TAX1BP1 interactions	MIA3 SWAP70 PRRC2C GPATCH4 MAP7 CCDC86 CXXC1	3.05e-04	342	76	7	int:TAX1BP1
Interaction	CDX2 interactions	ATRX SMARCA2 SMARCA4 ZNF292	3.14e-04	86	76	4	int:CDX2
Interaction	ZC3H13 interactions	CHD8 RNF40 EZH1 BAP1 DHX8	3.28e-04	158	76	5	int:ZC3H13
Interaction	RAD51AP1 interactions	ATRX SMARCA2 PALB2	3.36e-04	36	76	3	int:RAD51AP1
Interaction	CTCF interactions	ATRX NOP53 MKI67 SMARCA4 CHD8 MTDH RPL18 KPNA3	3.41e-04	461	76	8	int:CTCF
Interaction	NHLH1 interactions	NOP53 MKI67 SMARCA2 GPATCH4	3.43e-04	88	76	4	int:NHLH1
Interaction	KDM6A interactions	KAT8 SMARCA4 CXXC1 MTDH BAP1	3.68e-04	162	76	5	int:KDM6A
Interaction	DAXX interactions	ATRX MKI67 GPATCH4 FAS CCDC86 CXXC1 CBX2	3.70e-04	353	76	7	int:DAXX
Interaction	TBP interactions	BDP1 TRIM33 SMARCA2 TAF1 DBR1 CXXC1	3.87e-04	253	76	6	int:TBP
Interaction	CBX5 interactions	ATRX MKI67 SMARCA2 SMARCA4 BAP1 ZNF292 KPNA3	3.89e-04	356	76	7	int:CBX5
Interaction	INSRR interactions	LEMD3 NOP53 CXXC1 MTDH	4.23e-04	93	76	4	int:INSRR
Interaction	ZC3H18 interactions	MEAF6 CRACD NOP53 PRRC2C GPATCH4 RNF40 CCDC86 MTDH DHX8 RPL18 KPNA3	4.29e-04	877	76	11	int:ZC3H18
Interaction	FBXO42 interactions	BDP1 CEP85 MYO9B ASPM MAP7 GOLGB1	4.38e-04	259	76	6	int:FBXO42
Interaction	NANOG interactions	TRIM33 LEMD3 KAT8 GPS2 SMARCA2 SMARCA4 CCDC86 CBX2	4.52e-04	481	76	8	int:NANOG
Interaction	MTREX interactions	TRIM33 FAM107A NOP53 DBR1 MTDH DHX8	4.66e-04	262	76	6	int:MTREX
Interaction	NPM3 interactions	NOP53 MKI67 FAS BAP1 RPL18 KPNA3	4.66e-04	262	76	6	int:NPM3
Interaction	ERICH6B interactions	ATP5IF1 MTDH	4.97e-04	9	76	2	int:ERICH6B
Interaction	RPL10A interactions	MAP9 NOP53 MKI67 GPATCH4 MTDH BAP1 DHX8 RPL18	5.11e-04	490	76	8	int:RPL10A
Interaction	ALDH1L2 interactions	CHD8 FAS BAP1	5.32e-04	42	76	3	int:ALDH1L2
Interaction	BRD3 interactions	MYO9B MKI67 SMARCA2 SMARCA4 CHD8 TAF1 CCDC86 KPNA3	5.39e-04	494	76	8	int:BRD3
Interaction	MYCN interactions	MEAF6 CEP85 NOP53 PRRC2C MKI67 SMARCA2 SMARCA4 GPATCH4 MAP7 C2orf49 CCDC86 MTDH RPL18 KPNA3	5.52e-04	1373	76	14	int:MYCN
Interaction	SIRT6 interactions	MIA3 ATRX LEMD3 MKI67 SMARCA2 SMARCA4 CHD8 RNF40 RPL18	5.80e-04	628	76	9	int:SIRT6
Interaction	FASN interactions	MEAF6 TRIM33 CEP85 TADA2B GPS2 ASPM CHD8 GPATCH4 RNF40 MTDH BAP1 ZNF292	5.89e-04	1062	76	12	int:FASN
Interaction	CNBP interactions	MEAF6 NOP53 PRRC2C CCDC86 BAP1 RPL18	6.12e-04	276	76	6	int:CNBP
Interaction	MKRN2 interactions	CEP85 ATRX NOP53 PRRC2C TAF1 EZH1 FAS	6.20e-04	385	76	7	int:MKRN2
Interaction	SNRNP40 interactions	NOP53 MKI67 SMARCA4 GPATCH4 C2orf49 MTDH DHX8 CBX2 KPNA3	6.42e-04	637	76	9	int:SNRNP40
Interaction	XRCC6 interactions	ATRX SWAP70 NOP53 MKI67 SMARCA4 CHD8 TAF1 MTDH VAV1 BAP1 DHX8	6.87e-04	928	76	11	int:XRCC6
Interaction	ENY2 interactions	PRRC2C TADA2B PALB2 GOLGB1 RPL18	6.90e-04	186	76	5	int:ENY2
Interaction	CENPE interactions	RABEP1 MKI67 ASPM CBX2	6.94e-04	106	76	4	int:CENPE
Interaction	PDZRN3 interactions	FAM13C TAF1 PDZRN3	6.96e-04	46	76	3	int:PDZRN3
Interaction	ATN1 interactions	ATRX KAT8 PITX1 TAF1 CXXC1	7.07e-04	187	76	5	int:ATN1
Interaction	RB1 interactions	BDP1 SMARCA2 SMARCA4 RNF40 TAF1 FAS KPNA3	7.10e-04	394	76	7	int:RB1
Interaction	TAF10 interactions	TADA2B MKI67 SMARCA4 TAF1	7.18e-04	107	76	4	int:TAF10
Interaction	MKI67 interactions	NOP53 MKI67 ASPM SMARCA2 CHD8 GPATCH4 CCDC86 CXXC1 RPL18	7.25e-04	648	76	9	int:MKI67
Interaction	TAF9B interactions	TADA2B MKI67 CHD8 TAF1	7.44e-04	108	76	4	int:TAF9B
Interaction	MCM6 interactions	TRIM33 ATRX MKI67 MTDH BAP1 KPNA3	7.51e-04	287	76	6	int:MCM6
Interaction	RBBP5 interactions	KAT8 MKI67 SMARCA2 CHD8 TAF1 CXXC1	7.51e-04	287	76	6	int:RBBP5
Interaction	AOX1 interactions	TRIM33 SMARCA2	7.55e-04	11	76	2	int:AOX1
Interaction	RPL11 interactions	BDP1 NOP53 PRRC2C GPATCH4 CCDC86 MTDH BAP1 RPL18 KPNA3	7.58e-04	652	76	9	int:RPL11
Interaction	TEP1 interactions	NOP53 MAP7 MTDH	7.89e-04	48	76	3	int:TEP1
Interaction	BUD13 interactions	GPATCH4 EZH1 DHX8 RPL18	7.97e-04	110	76	4	int:BUD13
Cytoband	16p11.2	NPIPB8 NPIPB7 NPIPB6 NPIPB11 KAT8	1.95e-05	191	78	5	16p11.2
Cytoband	Ensembl 112 genes in cytogenetic band chr16p11	NPIPB8 NPIPB9 NPIPB11 KAT8 RNF40	1.16e-04	278	78	5	chr16p11
Cytoband	Ensembl 112 genes in cytogenetic band chr2q11	ANKRD36B ANKRD36 ANKRD36C	2.30e-03	153	78	3	chr2q11
Cytoband	Ensembl 112 genes in cytogenetic band chr16p12	NPIPB7 NPIPB6 PALB2	3.20e-03	172	78	3	chr16p12
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	BDP1 TADA2B EZH1	2.89e-04	53	44	3	532
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	KAT8 TAF1	7.69e-04	17	44	2	486
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	BDP1 CRACD ATRX RABEP1 TADA2B MKI67 ASPM LRRCC1 GPATCH4 DBR1 CCDC86 MTDH PALB2 DHX8 ZNF292 NAA16	6.41e-06	1257	75	16	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	MEAF6 TRIM33 CRACD ATRX FAM13C TADA2B MKI67 TAF1 GOLGB1 DHX8 ZNF292	7.35e-06	595	75	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	BDP1 ATRX PRRC2C RABEP1 ASPM LRRCC1 GPATCH4 ZNF292 NAA16	4.00e-05	469	75	9	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	BDP1 CRACD ATRX RABEP1 TADA2B MKI67 ASPM LRRCC1 GPATCH4 DBR1 CCDC86 MTDH PALB2 DHX8 ZNF292 NAA16	4.05e-05	1459	75	16	facebase_RNAseq_e10.5_Emin_LatNas_2500
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	BDP1 ATRX PRRC2C ASPM GPATCH4 ANKRD36 ANKRD36C GOLGB1 ZNF292	6.92e-11	197	78	9	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	TRIM33 MAP9 ATRX RABEP1 SMARCA2 LRRCC1 GOLGB1	5.83e-08	198	78	7	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 ATRX PRRC2C ANKRD36 ANKRD36C GOLGB1 ZNF292	6.03e-08	199	78	7	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	PRRC2C MKI67 ASPM ANKRD36 ANKRD36C ZNF292	1.11e-06	192	78	6	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAP9 ATRX PRRC2C ANKRD36 ANKRD36C ZNF292	1.22e-06	195	78	6	ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCell	Control-Neu_4\|Control / 5 Neutrophil clusters in COVID-19 patients	BDP1 LEMD3 MKI67 ASPM MTDH RPL18	1.25e-06	196	78	6	b8b7b54ca17a08fa775507bb22b1c7248ada8f40
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	TRIM33 ATRX PRRC2C ANKRD36 ANKRD36C ZNF292	1.33e-06	198	78	6	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	ANKRD36B MAP9 PRRC2C SMARCA2 ANKRD36 GOLGB1	1.37e-06	199	78	6	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	ATRX PRRC2C SMARCA2 ANKRD36 GOLGB1 ZNF292	1.37e-06	199	78	6	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TRIM33 MYO9B ZMAT1 GOLGB1 ZNF292	4.00e-06	135	78	5	b7a792a7c0c22d8b703509f134115f0e394d7de0
ToppCell	Adult-Mesenchymal-myofibroblast_cell-D122\|Adult / Lineage, Cell type, age group and donor	CRACD FAM107A FAM13C PDZRN3 CBX2	8.60e-06	158	78	5	410fa08c9d880d27e80ec939fa5ba5a41dcb31ab
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CEP85 MKI67 ASPM ANKRD36C CBX2	1.33e-05	173	78	5	20889aa85e36ad3bafdb91b91e43964493c949f9
ToppCell	368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CEP85 MKI67 ASPM ANKRD36C CBX2	1.33e-05	173	78	5	46e601b7938b1dd0aa3df7aa056c4bd07b1620c1
ToppCell	C_00\|World / shred on cell type and cluster	PRRC2C MKI67 ASPM ANKRD36 GOLGB1	1.57e-05	179	78	5	da2dadc3266ffebd4a34ac61bfa05fddcadcde4c
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANKRD36B NPIPB15 ANKRD36 ANKRD36C GOLGB1	1.80e-05	184	78	5	01c19a830348ab0b9c02c1546a439de70ee10f97
ToppCell	facs-Diaphragm-Limb_Muscle-18m-Lymphocytic\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TFEC DEF6 MKI67 ASPM VAV1	1.94e-05	187	78	5	e53471c3e146a6f54788d81ecc469aba55b051bb
ToppCell	facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TFEC DEF6 MKI67 ASPM VAV1	1.94e-05	187	78	5	3d7d51fbadb20dc884d0b3c0d61b80f022b19d09
ToppCell	5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PIEZO2 FAM13C CHD8 CCDC86 CBX2	1.99e-05	188	78	5	524d1d928c9386acf20e53d31894107dd7290dc7
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANKRD36B FAM107A SWAP70 ANKRD36 CBX2	1.99e-05	188	78	5	a37edd8f9e4a4e336b5acbb0407d3d275975cee8
ToppCell	5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PIEZO2 FAM13C CHD8 CCDC86 CBX2	1.99e-05	188	78	5	1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5
ToppCell	5'-Airway_Nasal-Endothelial-Blood_vessel_EC\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PIEZO2 FAM13C CHD8 CCDC86 CBX2	1.99e-05	188	78	5	cd2d1f8e43c252dd8730a5758458ef63e7ffc836
ToppCell	5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PIEZO2 FAM13C CHD8 CCDC86 CBX2	1.99e-05	188	78	5	f5a2f324f3f6c5078d57130392d3f1ba74f29094
ToppCell	5'-Airway_Nasal-Endothelial\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PIEZO2 FAM13C CHD8 CCDC86 CBX2	1.99e-05	188	78	5	6c9d5e4014f807149328ff4eabd5e86dfe18094d
ToppCell	ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells\|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ATRX NOP53 ZMAT1 GOLGB1 ZNF292	2.04e-05	189	78	5	a0634d72bfdd5f93877724ed6480b50a3a046f71
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANKRD36B NPIPB15 ANKRD36 ANKRD36C GOLGB1	2.10e-05	190	78	5	23f2ac4da431211084bb6ab0494c2e0b69547cb6
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANKRD36B NPIPB15 ANKRD36 ANKRD36C GOLGB1	2.10e-05	190	78	5	3c337374d89e69cc0a78e65a4a7e21db7b050fcd
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	CNNM2 FAM107A PITX1 BAP1 RPL18	2.10e-05	190	78	5	7179f980f895d3e5b839b5ae26b5c991787bfe3a
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	BDP1 TFEC SWAP70 MYO9B CCDC191	2.26e-05	193	78	5	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX PRRC2C MKI67 ASPM SMARCA4	2.32e-05	194	78	5	8ef0b71fef5b84cfd04973f891215333e7035d1d
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANKRD36B PITX1 ANKRD36 ANKRD36C GOLGB1	2.37e-05	195	78	5	3f8ed20ad17afe1545e574e5ca5fe33c3704c7f3
ToppCell	droplet-Thymus-nan-21m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP5IF1 DEF6 MKI67 SMARCA4 FAS	2.37e-05	195	78	5	2416efe0b10ef28d0107808d1347bc34f87f92b7
ToppCell	(1)_T_cells-(1)_T_CD4_naive\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ANKRD36B ATRX ANKRD36 ANKRD36C NAA16	2.37e-05	195	78	5	d3fa551bc6f5ee5890af1040415e61ecd5d46201
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PRRC2C SMARCA2 ANKRD36 ANKRD36C ZNF292	2.49e-05	197	78	5	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	Mild\|World / Condition, Lineage, Cell class and cell subclass	BDP1 MIA3 ATRX DEF6 GOLGB1	2.49e-05	197	78	5	476b0d0389f9fcd4614f6bb1f494281f467f6730
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	NOP53 ANKRD36 ANKRD36C NAA16 RPL18	2.49e-05	197	78	5	836dd8110d5689f944ad1d301def38c32278b5b5
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	ATRX PRRC2C RABEP1 GOLGB1 ZNF292	2.61e-05	199	78	5	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M\|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type.	CRACD SMARCA2 ANKRD36 ANKRD36C PDZRN3	2.61e-05	199	78	5	b2d7dea11207cca63d688f8051143850b29dbdf0
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	ATRX PRRC2C SMARCA2 GOLGB1 ZNF292	2.61e-05	199	78	5	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	ATRX PRRC2C MTDH GOLGB1 ZNF292	2.61e-05	199	78	5	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 ATRX PRRC2C GOLGB1 ZNF292	2.68e-05	200	78	5	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	(18)_cycling_gd_T\|World / shred on Cell_type and subtype	CEP85 ATRX MKI67 ASPM CBX2	2.88e-05	203	78	5	7d58929058c4769226a29febee1fd8ba64bc9f1a
ToppCell	3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	PRRC2C ANKRD36 ANKRD36C GOLGB1	9.31e-05	135	78	4	ae2d3a42e567b5bade304c0caa497eb725be3565
ToppCell	356C-Fibroblasts-Fibroblast-E\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TFEC NPIPB15 CCDC191 ZMAT1	9.58e-05	136	78	4	edfd453c9a650d69d05a5a3ab15f7df56349fa86
ToppCell	356C-Fibroblasts-Fibroblast-E-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TFEC NPIPB15 CCDC191 ZMAT1	9.58e-05	136	78	4	03e4e2353c23ceffde35b2d0aadd15299e3db09f
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	ANKRD36B PRRC2C ANKRD36 ANKRD36C	1.43e-04	151	78	4	999c11d19b61d6b130ad5e623afa83cbdfe13cdd
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPR65 PPFIA4 MKI67 VAV1	1.67e-04	157	78	4	904cd98ae85ed6459e0663f077ac462842bf12df
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAM13C PPFIA4 ANO1 PDZRN3	1.71e-04	158	78	4	84c0a215dabf697ada036c2b9592d0c61b5077de
ToppCell	VE-CD8-CD4_Treg\|VE / Condition, Cell_class and T cell subcluster	GKAP1 ANKRD36 EZH1 CCDC86	1.83e-04	161	78	4	a114f4f75859d9ef900e5146686438d051241429
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPR65 MKI67 ASPM CCDC86	1.88e-04	162	78	4	ec29c6f1c31e41ddcb041a49c593910edaf0532c
ToppCell	severe-Lymphocytic-B_cells_2\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MAP9 SWAP70 NOP53 RPL18	1.97e-04	164	78	4	a1031e9f945a15186ee14c12be47aa11c3c6583b
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TFEC GPR65 ASPM VAV1	2.01e-04	165	78	4	cece16b03282d27fb49102eb9c104a2024efd28c
ToppCell	remission-HSPC\|World / disease stage, cell group and cell class	CRACD LRRCC1 MAP7 CBX2	2.06e-04	166	78	4	d269ee6f7adb55b05dcb5eaea96629ccb0b2d6e3
ToppCell	Healthy_donor-HSPC\|World / disease group, cell group and cell class (v2)	CRACD PPFIA4 MAP7 CBX2	2.11e-04	167	78	4	70630ebdfee8171d625811844f8a7c94736d101e
ToppCell	droplet-Bladder-BLADDER-1m-Hematologic-macrophage\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR65 PPFIA4 PALB2 VAV1	2.11e-04	167	78	4	1a6a48180481f0c13c15bb93d6ff4eeb96a5b9a0
ToppCell	Adult-Mesenchymal-myofibroblast_cell\|Adult / Lineage, Cell type, age group and donor	CRACD FAM13C PDZRN3 CBX2	2.11e-04	167	78	4	d584a8548a5317bd9686b3be8246ae6ed568796b
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	NPIPB11 CCDC86 CCDC191 ZNF292	2.16e-04	168	78	4	8697b40b2ec2cce68ef3beb4792eb3eff29be053
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CRACD MKI67 ASPM ANO1	2.31e-04	171	78	4	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	PRRC2C ANKRD36 ANKRD36C GOLGB1	2.31e-04	171	78	4	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CRACD MKI67 ASPM ANO1	2.31e-04	171	78	4	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANKRD36B MKI67 ASPM FAS	2.36e-04	172	78	4	eee45759284baa3ed77da6a5fbcc4f8f6c553106
ToppCell	facs-Aorta-Heart-24m-Myeloid-macrophage\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPFIA4 DEF6 CCDC86 VAV1	2.41e-04	173	78	4	d0d1c8bcef3d9c28ee9a7c64076624b836cb2580
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRACD PIEZO2 MKI67 ASPM	2.41e-04	173	78	4	f38bf7584e08d15a6e2c116b7c3551ba475a5e14
ToppCell	facs-Aorta-Heart-3m-Myeloid\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR65 PPFIA4 MKI67 VAV1	2.41e-04	173	78	4	513b4d31bcfb269556c6b4cc389865fb12e52c4f
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	NPIPB15 NPIPB9 MKI67 ASPM	2.63e-04	177	78	4	d2c1f46913ac00bbc0bb9320d5652edc01b34179
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	NPIPB15 NPIPB9 MKI67 ASPM	2.63e-04	177	78	4	65e090aad0ffb737ce034e25bd5b12a0b1dd9684
ToppCell	VE-CD4-proli_CD4\|VE / Condition, Cell_class and T cell subcluster	FAM13C NPIPB9 NOP53 RPL18	2.69e-04	178	78	4	f0a0cbf73e03f1b29f0be6598517c8a1da41c8dc
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANKRD36B NPIPB15 ANKRD36C GOLGB1	2.75e-04	179	78	4	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CRACD PIEZO2 ASPM ANO1	2.93e-04	182	78	4	08aff7112c9dac0ef5540300516a604782b21169
ToppCell	facs-Aorta-Heart-3m-Myeloid-macrophage\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR65 PPFIA4 MKI67 VAV1	2.93e-04	182	78	4	df26388c0c46d1c4775103c8e802937b4d4e7470
ToppCell	PND10-Immune-Immune_Myeloid-Dendritic-cDC1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPR65 MKI67 ASPM VAV1	2.99e-04	183	78	4	ab38264daddccdf5ffb75ff2210b27423eca6bc0
ToppCell	PND10-Immune-Immune_Myeloid-Dendritic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPR65 MKI67 ASPM VAV1	2.99e-04	183	78	4	e4911601dca2c0ecb448cdb6b222dedfc0c8bf6c
ToppCell	PND10-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPR65 MKI67 ASPM VAV1	2.99e-04	183	78	4	263bfa1d8a7314bc3156c735c403c3bab8ea4dac
ToppCell	facs-Aorta-Heart-3m-Myeloid-leukocyte\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR65 PPFIA4 MKI67 VAV1	2.99e-04	183	78	4	062ec08d66c923f90fee771b1bf8d98bdc7e6c1b
ToppCell	343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	TFEC MKI67 ASPM PALB2	2.99e-04	183	78	4	f03d87b556a3d50360d4eb6126b3466fe7266677
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TFEC SWAP70 MXD4 GOLGB1	2.99e-04	183	78	4	614a1c08cf6d01a4f1ed2fb816cd1a6e0c3207ce
ToppCell	facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-T_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TFEC MKI67 ASPM VAV1	3.05e-04	184	78	4	185b49630da61cbf45c0926d1b992943296d2a54
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_B-GC_B_(I)\|lymph-node_spleen / Manually curated celltypes from each tissue	MKI67 ASPM MAP7 CCDC86	3.05e-04	184	78	4	057c6c2f570914fa4af84682589a86b61547d6c9
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CNNM2 FAM13C ANO1 CCDC86	3.18e-04	186	78	4	6568358812f0ca4e0161a1a1b29682fbced35c79
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP5IF1 MKI67 ASPM RPL18	3.18e-04	186	78	4	15ab6666748a641226e42e6ca6eeaf186a501c95
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP5IF1 MKI67 ASPM RPL18	3.18e-04	186	78	4	4ed1b97e2552f3c4134f25665d7513498ffac16c
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	TRIM33 CRACD ATRX TAF1	3.18e-04	186	78	4	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	NPIPB15 NPIPB9 MKI67 ASPM	3.24e-04	187	78	4	88d20f150df61ef0e3ee0c3e9895b094920c4b09
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CRACD PIEZO2 ASPM ANO1	3.24e-04	187	78	4	d413fb4b1531b297af5012a392b88128510c2de8
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	NPIPB15 NPIPB9 MKI67 ASPM	3.24e-04	187	78	4	158c2c003fd225ba61793fb06eece232fb063d05
ToppCell	facs-Lung-24m-Hematologic-myeloid-leukocyte\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TFEC MAP9 CEP85 LRRCC1	3.31e-04	188	78	4	61b6047affa18c5e71210fcce449e2bbe7cf141b
ToppCell	facs-Lung-24m-Hematologic-myeloid-leukocyte-proliferating_myeloid_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TFEC MAP9 CEP85 LRRCC1	3.31e-04	188	78	4	797ce39602f0f78081eb44a21da0d9443f7fd9cf
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BDP1 MAP9 SWAP70 CCDC191	3.38e-04	189	78	4	b13f315f617840eb5143a4e8a33a657c20365c21
ToppCell	normal-na-Lymphocytic_B-B_plasma\|normal / PBMC cell types (v2) per disease, treatment status, and sex	NPIPB15 NPIPB9 MKI67 ASPM	3.38e-04	189	78	4	659deb617a560bcde67c75f477d30ce85aaec3c6
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	NPIPB15 NPIPB9 MKI67 ASPM	3.38e-04	189	78	4	59e6fec454de621119571d4a8ec48be3bf02a32e
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	NPIPB15 NPIPB9 MKI67 ASPM	3.38e-04	189	78	4	43f25fb7257eab05df921ffcd5a6e49c78a03e3a
ToppCell	normal-na-Lymphocytic_B-B_plasma-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	NPIPB15 NPIPB9 MKI67 ASPM	3.38e-04	189	78	4	67f9a9861d2dcc128b7a69432c6b31da185e2249
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	TFEC GPR65 DEF6 VAV1	3.44e-04	190	78	4	081b7bc07b6e5685e8a91b9ae6c1141623723700
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TADA2B EZH1 CXXC1 PALB2	3.44e-04	190	78	4	63018acb7ad80415e861643162abdc2e55968ee4
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ATRX SMARCA2 SMARCA4 GOLGB1	3.44e-04	190	78	4	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX PRRC2C MTDH GOLGB1	3.51e-04	191	78	4	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	Dividing_Macrophages-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	ATRX MKI67 SCN10A ASPM	3.51e-04	191	78	4	3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAP9 PRRC2C GOLGB1 ZNF292	3.51e-04	191	78	4	1ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX PRRC2C MTDH GOLGB1	3.51e-04	191	78	4	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	RV-08._Macrophage\|World / Chamber and Cluster_Paper	TFEC MKI67 ASPM VAV1	3.58e-04	192	78	4	a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3
ToppCell	PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_proliferating_myeloid_(8)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TFEC GPR65 DEF6 VAV1	3.58e-04	192	78	4	b204ef6e05170855259b902829a1700094eb9159
Computational	Genes upregulated in subsets of cells of a given type within various tumors	BDP1 ATRX GOLGB1 ZNF292	7.52e-05	49	50	4	GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
Computational	Genes upregulated in subsets of cells of a given type within various tumors	BDP1 ATRX GOLGB1 ZNF292	8.15e-05	50	50	4	GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1
Drug	Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; PC3; HT_HG-U133A	TRIM33 MYO9B PITX1 RNF40 PLCB3 EZH1 PALB2 DHX8	3.48e-07	200	76	8	7261_DN
Drug	Piroxicam [36322-90-4]; Down 200; 12uM; MCF7; HT_HG-U133A	CNNM2 SWAP70 RABEP1 PITX1 SMARCA2 EZH1 C2orf68	4.45e-06	198	76	7	7445_DN
Drug	Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; MCF7; HT_HG-U133A	ATRX MYO9B SMARCA2 MAP7 PDZRN3 ZNF292 RPL18	4.45e-06	198	76	7	2623_DN
Drug	Clorgyline	BDP1 MAP9 ATRX FAS GOLGB1 ZNF292	2.10e-05	168	76	6	ctd:D003010
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA	TRIM33 PRRC2C RABEP1 SMARCA4 MTDH ZNF292	2.82e-05	177	76	6	985_DN
Drug	Imipenem [74431-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A	MAP9 MYO9B KAT8 PITX1 PLCB3 ATP8B1	4.33e-05	191	76	6	5997_DN
Drug	PHA-00846566E [724718-26-7]; Down 200; 10uM; PC3; HT_HG-U133A	MIA3 ATRX MAP7 C2orf68 MXD4 DHX8	4.33e-05	191	76	6	7086_DN
Drug	Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A	CEP85 ATRX PRRC2C MKI67 ASPM VAV1	4.45e-05	192	76	6	7176_DN
Drug	Pentoxifylline [6493-05-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A	KAT8 PLCB3 ATP8B1 C2orf68 VAV1 RPL18	4.72e-05	194	76	6	6021_DN
Drug	Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; MCF7; HT_HG-U133A	CNNM2 CEP85 ATRX C2orf68 MXD4 RPL18	5.00e-05	196	76	6	5318_UP
Drug	Gossypol [303-45-7]; Down 200; 7.8uM; PC3; HT_HG-U133A	MKI67 SMARCA4 RNF40 FAS MXD4 BAP1	5.00e-05	196	76	6	4296_DN
Drug	LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A	ATRX KAT8 PITX1 PLCB3 MAP7 CXXC1	5.14e-05	197	76	6	5576_DN
Drug	Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A	MYO9B PITX1 PLCB3 FAS C2orf68 MXD4	5.14e-05	197	76	6	4730_DN
Drug	S(-)-terguride hydrogen maleate [37686-85-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A	MAP9 PITX1 FAS CXXC1 C2orf68 MXD4	5.14e-05	197	76	6	5694_DN
Drug	Diazoxide [364-98-7]; Down 200; 17.4uM; MCF7; HT_HG-U133A	CNNM2 CEP85 RABEP1 C2orf68 VAV1 BAP1	5.29e-05	198	76	6	7168_DN
Drug	Epirizole [18694-40-1]; Down 200; 17uM; MCF7; HT_HG-U133A	MAP9 MYO9B PITX1 PLCB3 TAF1 C2orf68	5.29e-05	198	76	6	5995_DN
Drug	Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; MCF7; HT_HG-U133A	KAT8 PLCB3 EZH1 C2orf68 VAV1 ZNF292	5.29e-05	198	76	6	3219_DN
Drug	Homosalate [118-56-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A	MAP9 SWAP70 EGR4 PITX1 DEF6 RPL18	5.29e-05	198	76	6	3879_UP
Drug	Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A	MYO9B PITX1 SMARCA2 MXD4 VAV1 RPL18	5.44e-05	199	76	6	3344_DN
Disease	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	SMARCA2 SMARCA4	6.34e-05	5	75	2	C3281201
Disease	opportunistic bacterial infectious disease (implicated_via_orthology)	SMARCA2 SMARCA4	2.27e-04	9	75	2	DOID:0050340 (implicated_via_orthology)
Disease	von Willebrand factor measurement, coronary artery disease	CNNM2 MIA3 OR13C5 SMARCA4	2.37e-04	118	75	4	EFO_0001645, EFO_0004629
Disease	autism	TRIM33 MYO9B BSX	2.51e-04	48	75	3	EFO_0003758
Disease	Neuroendocrine Tumors	ATRX BAP1	3.45e-04	11	75	2	C0206754
Disease	Barrett's esophagus (is_marker_for)	MKI67 FAS	3.45e-04	11	75	2	DOID:9206 (is_marker_for)
Disease	Malignant neoplasm of ovary	FAM107A MKI67 SMARCA4 BAP1	4.19e-04	137	75	4	C1140680
Disease	Coffin-Siris syndrome	SMARCA2 SMARCA4	4.88e-04	13	75	2	C0265338
Disease	fibrinogen measurement, coronary artery disease	CNNM2 MIA3 SWAP70 SMARCA4	6.50e-04	154	75	4	EFO_0001645, EFO_0004623
Disease	congenital heart disease (implicated_via_orthology)	CHD8 RNF40 NAA16	7.33e-04	69	75	3	DOID:1682 (implicated_via_orthology)
Disease	Cardiovascular Abnormalities	KAT8 ZNF292	7.48e-04	16	75	2	C0243050
Disease	level of Sphingomyelin (d32:1) in blood serum	RABEP1 SMARCA4	8.46e-04	17	75	2	OBA_2045173
Disease	Feeding difficulties	KAT8 ZNF292	9.50e-04	18	75	2	C0232466
Disease	Hereditary Non-Polyposis Colon Cancer Type 2	SMARCA4 PALB2	1.06e-03	19	75	2	C1333991
Disease	Colorectal cancer, hereditary nonpolyposis, type 1	SMARCA4 PALB2	1.06e-03	19	75	2	C2936783
Disease	intrahepatic cholangiocarcinoma (is_marker_for)	FAS BAP1	1.06e-03	19	75	2	DOID:4928 (is_marker_for)
Disease	lung cancer	ATP8B1 MAP7	1.30e-03	21	75	2	MONDO_0008903
Disease	lung adenocarcinoma (is_marker_for)	ATRX MKI67 FAS	1.34e-03	85	75	3	DOID:3910 (is_marker_for)
Disease	Agents acting on the renin-angiotensin system use measurement	CNNM2 MIA3 SWAP70 MYO9B SMARCA4	1.65e-03	335	75	5	EFO_0009931
Disease	Schizophrenia	CNNM2 EGR4 MYO9B KAT8 SMARCA2 FAS CCDC86 KPNA3	1.79e-03	883	75	8	C0036341
Disease	large artery stroke, coronary artery disease	CNNM2 SMARCA4	1.84e-03	25	75	2	EFO_0001645, EFO_0005524
Disease	sexual dimorphism measurement	NPIPB8 MYO9B NPIPB6 PITX1 DEF6 SMARCA4 PLCB3 MXD4 KPNA3	1.93e-03	1106	75	9	EFO_0021796
Disease	Hereditary Nonpolyposis Colorectal Neoplasms	SMARCA4 PALB2	1.99e-03	26	75	2	C0009405
Disease	Adenoid Cystic Carcinoma	ATRX ASPM SMARCA2	2.14e-03	100	75	3	C0010606
Disease	Pancreatic Neoplasm	ATRX PALB2 BAP1	2.14e-03	100	75	3	C0030297
Disease	Hereditary non-polyposis colorectal cancer syndrome	SMARCA4 PALB2	2.15e-03	27	75	2	C1112155
Disease	attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia	CNNM2 SMARCA2 PALB2	2.20e-03	101	75	3	EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090
Disease	Malignant neoplasm of pancreas	ATRX PALB2 BAP1	2.26e-03	102	75	3	C0346647
Disease	Hereditary Nonpolyposis Colorectal Cancer	SMARCA4 PALB2	2.48e-03	29	75	2	C1333990

Protein segments in the cluster

Peptide	Gene	Start	Entry
KKREQHEIKNETKRS	C2orf49	76	Q9BVC5
IEKLRKREQKLNKHL	RNF40	286	O75150
EVDLNQKKRRRKKQD	BDP1	456	A6H8Y1
SQLEKDKRIHQKLKR	CHD8	686	Q9HCK8
HLEEEKERRRQEKKQ	CCDC86	286	Q9H6F5
KKVLHEEEKRRRKEQ	GPS2	91	Q13227
RRMKHKKQLRKSQDE	BSX	161	Q3C1V8
KRKKFKIDDQRRTHN	BAP1	656	Q92560
REKRRKKKEQQQSEA	GKAP1	56	Q5VSY0
QEKKKRRNVEEVHQK	ANKRD36	1441	A6QL64
KKKRRNVEELHQKVR	ANKRD36B	881	Q8N2N9
KKVKQAAKEKVRRRH	C2orf68	41	Q2NKX9
KLKTDLKRHQEREKA	ASPM	1281	Q8IZT6
DKIQKHRKRLKAEEQ	ATP8B1	1176	O43520
EERKQHLVKAKEQRR	PDZRN3	976	Q9UPQ7
QQRLNKRKDHKKADV	RABEP1	326	Q15276
LEHRRRNQLIKKKKE	FAM107A	71	O95990
KKLKKLREEEQQQHR	LEMD3	41	Q9Y2U8
KKKRRNVEELHQKVR	ANKRD36C	1306	Q5JPF3
LRKNKRDEHLLKKRN	KPNA3	36	O00505
KRKEHSEKKQRVRFQ	KIAA0100	1786	Q14667
KKTEQQRRREKAVHR	NOP53	336	Q9NZM5
KRAKVHIKKLEEQDR	MXD4	96	Q14582
KHLEERKKRLEEQRQ	MAP7	101	Q14244
EKQERIERKQKKRHS	MAP9	611	Q49MG5
RKITRNQKRKHDEIN	KAT8	136	Q9H7Z6
TQAEKDRRLKKKHQL	PPFIA4	801	O75335
RKSKKKRQQHQEEED	GPATCH4	376	Q5T3I0
RAQKKAKLEEERKHA	NAA16	601	Q6N069
RKRKVTTKINRHDKI	NPIPB8	176	E9PQR5
SLKKESRNKEKRRHI	ANO1	466	Q5XXA6
KVHLKQKARAEERLK	EGR4	561	Q05215
KRHLRTRVQKVQVKE	MKI67	2721	P46013
KIRKRKVTTKINRHD	NPIPB7	156	O75200
KDVKEAVKHLLRRKN	OR13C5	301	Q8NGS8
KIRKRKVTTKINRHD	NPIPB15	156	A6NHN6
KIRKRKVTTKINRHD	NPIPB11	156	E5RHQ5
QRAQRAEKIKHSIKK	PALB2	36	Q86YC2
KKELQKILDRKRHNS	PLCB3	1091	Q01970
KEHKEVKGRNRRKVS	ATRX	1361	P46100
KSEKKKEERYKRHRQ	CXXC1	336	Q9P0U4
KEHEKEVQNRKRGKR	CBX2	61	Q14781
KKQRVSKKHRRLAQD	CRACD	166	Q6ZU35
HKQVKENRLRREKEL	CCDC191	196	Q8NCU4
VKKQEERVKGRDKHI	CEP85	441	Q6P2H3
LHKDLKQKRREQREQ	DEF6	321	Q9H4E7
ISHREKRQQRKRDKV	MTDH	196	Q86UE4
RKNKNRHRIDLKLNK	MEAF6	171	Q9HAF1
EHEPEQRKKIKRRNQ	DBR1	516	Q9UK59
DQRTKRENIKEKRKA	CCDC174	276	Q6PII3
ERLQKEIERHKQKIK	ATP5IF1	86	Q9UII2
RKRKVTTKINRHDKI	NPIPB6	176	E9PJ23
KIRKRKVTTKINRHD	NPIPB9	171	F8W1W9
KQRDAEHRDRTKKKK	DHX8	161	Q14562
DDPAKKKKQRRQRTH	PITX1	81	P78337
QRVKFTKDHLIRKKE	TRIM33	246	Q9UPN9
QKIEQERKRRQKHQE	SMARCA2	436	P51531
ARHKREKRKENKNLA	TADA2B	311	Q86TJ2
CHRVQEENARLKKKK	MIA3	1346	Q5JRA6
KRKKKHRELIQEEQI	TAF1	261	P21675
SKKQQKRLQDEERRK	PRRC2C	1686	Q9Y520
EEEVRQKKSSRKRKR	SMARCA4	1401	P51532
KHIQSLKRKIRKFEE	FAM13C	291	Q8NE31
NRTKKKVAHRERKQD	CNNM2	591	Q9H8M5
LQIRSKKRKRQEEKH	TRIM61	81	Q5EBN2
RHNKDRKVRRKEPKS	RPL18	6	Q07020
KRKEVQKTCRKHRKE	FAS	191	P25445
KAREKHREQKDQEEK	SCN10A	36	Q9Y5Y9
KKDKLHRRAQDKKRN	VAV1	576	P15498
VTRKRKRHAIEGNKK	EZH1	211	Q92800
QRHKEKKRSAREERK	PIEZO2	1596	Q9H5I5
QTKGRKIRRHKKEKE	ZNF292	2076	O60281
RHNKATENKEKKRII	GPR65	211	Q8IYL9
HKEARQRRKELRKKQ	SWAP70	316	Q9UH65
KERQKKDNHNLIERR	TFEC	136	O14948
RKHRKEKKKSVEERT	ZMAT1	611	Q5H9K5
SRKAILKKAQEKERH	GOLGB1	1186	Q14789
KLERHNERKEKLKQQ	LRRCC1	871	Q9C099
AQKKKRKQERAVQEH	MYO9B	1616	Q13459